BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 21837731)

  • 21. Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria.
    De Giorgio M; Vezzoli S; Cohen E; Armellini E; Lucà MG; Verga G; Pinelli D; Nani R; Valsecchi MG; Antolini L; Colledan M; Fagiuoli S; Strazzabosco M
    Liver Transpl; 2010 Apr; 16(4):503-12. PubMed ID: 20373461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphological features of advanced hepatocellular carcinoma as a predictor of downstaging and liver transplantation: an intention-to-treat analysis.
    Barakat O; Wood RP; Ozaki CF; Ankoma-Sey V; Galati J; Skolkin M; Toombs B; Round M; Moore W; Mieles L
    Liver Transpl; 2010 Mar; 16(3):289-99. PubMed ID: 20209588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocellular carcinoma downstaging in liver transplantation.
    Yu CY; Ou HY; Huang TL; Chen TY; Tsang LL; Chen CL; Cheng YF
    Transplant Proc; 2012 Mar; 44(2):412-4. PubMed ID: 22410030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma.
    Silva M; Moya A; Berenguer M; Sanjuan F; López-Andujar R; Pareja E; Torres-Quevedo R; Aguilera V; Montalva E; De Juan M; Mattos A; Prieto M; Mir J
    Liver Transpl; 2008 Oct; 14(10):1449-60. PubMed ID: 18825681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiofrequency ablation of hepatocellular carcinoma as bridge therapy to liver transplantation: A 10-year intention-to-treat analysis.
    Lee MW; Raman SS; Asvadi NH; Siripongsakun S; Hicks RM; Chen J; Worakitsitisatorn A; McWilliams J; Tong MJ; Finn RS; Agopian VG; Busuttil RW; Lu DSK
    Hepatology; 2017 Jun; 65(6):1979-1990. PubMed ID: 28170115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beyond the Milan criteria: what risks for patients with hepatocellular carcinoma progression before liver transplantation?
    De Carlis L; Di Sandro S; Giacomoni A; Slim A; Lauterio A; Mangoni I; Mihaylov P; Pirotta V; Aseni P; Rampoldi A
    J Clin Gastroenterol; 2012 Jan; 46(1):78-86. PubMed ID: 21897282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toward optimizing the indications for orthotopic liver transplantation in hepatocellular carcinoma.
    Samuel D; Colombo M; El-Serag H; Sobesky R; Heaton N
    Liver Transpl; 2011 Oct; 17 Suppl 2():S6-13. PubMed ID: 21858912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate.
    Cescon M; Cucchetti A; Ravaioli M; Pinna AD
    J Hepatol; 2013 Mar; 58(3):609-18. PubMed ID: 23041304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis.
    Fuks D; Dokmak S; Paradis V; Diouf M; Durand F; Belghiti J
    Hepatology; 2012 Jan; 55(1):132-40. PubMed ID: 21932387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The best candidates for transarterial chemotherapy in patients with hepatocellular carcinoma awaiting liver transplantation: a cohort-based characterization of dropout times.
    Jang JW; Choi JY; Bae SH; Kim CW; Cho SH; Yoon SK; Yang JM; Han JY; Lee YS; Kim DG
    Aliment Pharmacol Ther; 2007 Jul; 26(1):87-94. PubMed ID: 17555425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment before liver transplantation for HCC.
    Belghiti J; Carr BI; Greig PD; Lencioni R; Poon RT
    Ann Surg Oncol; 2008 Apr; 15(4):993-1000. PubMed ID: 18236111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease era.
    Levi DM; Tzakis AG; Martin P; Nishida S; Island E; Moon J; Selvaggi G; Tekin A; Madrazo BL; Narayanan G; Garcia MT; Feun LG; Tryphonopoulos P; Skartsis N; Livingstone AS
    J Am Coll Surg; 2010 May; 210(5):727-34, 735-6. PubMed ID: 20421039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver transplantation for hepatocellular carcinoma in New Zealand: a prospective intent-to-treat analysis.
    Marui Y; McCall J; Gane E; Holden A; Duncan D; Yeong ML; Chow K; Munn S
    N Z Med J; 2005 Jun; 118(1217):U1532. PubMed ID: 15980906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A model for dropout assessment of candidates with or without hepatocellular carcinoma on a common liver transplant waiting list.
    Toso C; Dupuis-Lozeron E; Majno P; Berney T; Kneteman NM; Perneger T; Morel P; Mentha G; Combescure C
    Hepatology; 2012 Jul; 56(1):149-56. PubMed ID: 22271250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis.
    Kulik L; Heimbach JK; Zaiem F; Almasri J; Prokop LJ; Wang Z; Murad MH; Mohammed K
    Hepatology; 2018 Jan; 67(1):381-400. PubMed ID: 28859222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation.
    Cherqui D; Laurent A; Mocellin N; Tayar C; Luciani A; Van Nhieu JT; Decaens T; Hurtova M; Memeo R; Mallat A; Duvoux C
    Ann Surg; 2009 Nov; 250(5):738-46. PubMed ID: 19801927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of benefit of pre-transplant locoregional hepatic therapy for hepatocellular cancer in the current MELD era.
    Porrett PM; Peterman H; Rosen M; Sonnad S; Soulen M; Markmann JF; Shaked A; Furth E; Reddy KR; Olthoff K
    Liver Transpl; 2006 Apr; 12(4):665-73. PubMed ID: 16482577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Locoregional Therapy and Predictors for Dropout in Patients with Hepatocellular Carcinoma Listed for Liver Transplantation.
    Sheth RA; Patel MS; Koottappillil B; Shah JA; Oklu R; Mueller P; Vagefi PA; Ganguli S
    J Vasc Interv Radiol; 2015 Dec; 26(12):1761-8; quiz 1768. PubMed ID: 26419427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver transplantation for hepatocellular carcinoma: results of a multicenter study with common priorization criteria.
    Santoyo J; Sanchez B; de la Mata M; Fernández-Aguilar JL; Lopez-Ciller P; Pascasio JM; Suarez MA; Gomez MA; Nogueras F; Muffak K; Cuende N; Alonso M
    Transplant Proc; 2009 Apr; 41(3):1009-11. PubMed ID: 19376412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Superiority of transplantation versus resection for the treatment of small hepatocellular carcinoma.
    Baccarani U; Isola M; Adani GL; Benzoni E; Avellini C; Lorenzin D; Bresadola F; Uzzau A; Risaliti A; Beltrami AP; Soldano F; De Anna D; Bresadola V
    Transpl Int; 2008 Mar; 21(3):247-54. PubMed ID: 18028264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.